Trial
NCT02112630
Boceprevir in End Stage Renal Disease (ESRD)
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Merck Sharp & Dohme LLC
Condition
Hepatitis C Infection
Intervention
P-IFN alfa 2a
Why stopped
Poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-23